-+ 0.00%
-+ 0.00%
-+ 0.00%

Plus Therapeutics amends bylaws to reflect corporate name change to Cerenome

PUBT·08/04/2026 21:33:59
Listen to the news
Plus Therapeutics amends bylaws to reflect corporate name change to Cerenome
  • Plus Therapeutics amended its bylaws to reflect a corporate name change to Cerenome, effective Aug. 3, 2026.
  • Nasdaq trading symbol switched to CNSY at the start of trading on Aug. 3, 2026.
  • CUSIP for the common stock remains unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-332939), on August 04, 2026, and is solely responsible for the information contained therein.